发明名称 MUC-1 DERIVED PEPTIDES
摘要 Described are peptides and polypeptides derived from the MUC-1 polypeptide which are able to activate Cytotoxic T Lymphocyte (CTL) response, analogues of such peptides and polypeptides nucleotide sequences encoding such peptides and polypeptides and therapeutic uses thereof. Moreover, indications for selecting appropriate minimal antigenic MUC-1 polypeptides with reference to the HLA-type of the patient to be treated or tested are described.
申请公布号 WO0118035(A9) 申请公布日期 2002.09.06
申请号 WO2000EP08761 申请日期 2000.09.07
申请人 TRANSGENE S.A.;IMPERIAL CANCER RESEARCH TECHNOLOGY, LTD. 发明人 TAYLOR-PAPADIMITRIOU, JOYCE;HEUKAMP, LUKAS, CARL;OFFRINGA, RIENK;MELIEF, CORNELIS, JOHANNA, MARIA;ACRES, BRUCE;THOMAS, MIREILLE
分类号 C12N15/09;A61K31/7088;A61K35/12;A61K35/76;A61K38/00;A61K38/17;A61K39/00;A61K39/39;A61K48/00;A61P35/00;A61P37/06;A61P43/00;C07K7/06;C07K14/47;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/12;C12Q1/02;G01N33/50;G01N33/53;G01N33/68;(IPC1-7):C12N15/12 主分类号 C12N15/09
代理机构 代理人
主权项
地址